NCT05263492 2025-10-02Study of Lenvatinib w/ Pembro in Black Participants w/Mismatch Repair-Prof Recurrent Endometrial CancerVirginia Commonwealth UniversityPhase 2 Terminated4 enrolled 8 charts
NCT01133756 2023-06-22E7080 in Combination With Carboplatin + Gemcitabine Versus Carboplatin + Gemcitabine Alone as Second Line Therapy in Patients With Platinum-Sensitive Recurrent Ovarian Cancer by CA125Eisai Inc.Phase 1/2 Terminated7 enrolled 6 charts